<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               1	INDICATIONS AND USAGE<BR>               <BR>                  <BR>                     Elitek<BR>                           Â®<BR>                         is indicated for the initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid.<BR>                  <BR>                  <BR>                     Limitation of use: Elitek is indicated only for a single course of treatment [see Warnings and Precautions (5.1)].<BR>                     <BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                        Elitek is a recombinant urate-oxidase indicated for initial management of plasma uric acid levels in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis and subsequent elevation of plasma uric acid (1). <BR>                        Limitation of use: Elitek is indicated only for a single course of treatment (1).<BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>